SecBot SecBot
Insider Buy ·Filed Sep 15, 2026

NAMS

NewAmsterdam Pharma Co N.V.
BULLISH
Impact 5/10
Horizonweeks Processed2mo ago SEC0001193125-26-391985
Insider cluster: 1 insiders, $227K total
Actionable Insight ▲ Bullish

The CEO's open-market buy is a modest bullish signal, but the dollar amount is small relative to market cap. Given the ticker's historical pattern of high-score reports underperforming, treat this as a modest positive signal rather than a strong catalyst. Monitor for additional insider buying or upcoming catalysts (e.g., Phase 3 data, regulatory updates) to confirm conviction.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$21.18
T+0 close · Sep 15, 2026 · via day close
Latest settled
−5.52%
T+20 · $20.01 · next T+60 in 23d
Vs SPY
−7.59%
α at T+20
Latest observation
−0.17%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $21.18entry
  2. T+1 · 2mo ago +3.54%α +2.41% · $21.93
  3. T+5 · 8w ago +7.08%α +5.26% · $22.68
  4. T+20 · 5w ago −5.52%α −7.59% · $20.01
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Michael Davidson purchased $227K of NAMS stock on the open market at $22.65/share, a standalone conviction buy. This is a bullish signal from the highest-ranking insider, though the dollar amount is modest relative to the $2.5B market cap (~0.009%). The buy is not part of a 10b5-1 plan and comes amid strong analyst consensus (91% bullish).

Key Financial Metrics

Direction
buying
Total Value
$226.5K
Insiders
1

Key Facts

  • CEO Michael H. Davidson purchased 10,000 shares of NAMS at $22.65/share on 2026-09-14, totaling $227K.
  • The purchase is an open-market buy (SEC Form 4 code P), not a 10b5-1 plan or grant.
  • Market cap is $2.5B; the buy represents ~0.009% of market cap, below the 0.1% materiality threshold.
  • Analyst consensus is 91% bullish (9 Strong Buy, 12 Buy, 2 Hold).

Financial Impact

CEO purchased $227K of common stock at $22.65/share; no financial impact on company operations.

dilution

Risk Factors

  • The $227K purchase is only ~0.009% of market cap, which is below the 0.1% materiality threshold for insider buys.
  • A single insider buy, even from the CEO, has limited predictive power without corroborating cluster activity or corporate catalysts.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001193125-26-391985

Track record

8 reports on NAMS

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +7.23% at T+5 after the Sep 22, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $18.89 to $18.90 Now $19.46 +3.02% ▲ +0.05% −0.26% vs SPY
  2. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $20.93 to $18.89 Now $19.46 −7.02% ▼ −9.75% −5.34% vs SPY
  3. Sep 29, 20266w ago 8-K Neutral 4/10 Entry $23.81 to $24.32 Now $19.46 −18.27% ▲ +2.14% +2.35% vs SPY
  4. Sep 22, 20267w ago SC 13D/A Bullish 5/10 Entry $22.68 to $22.74 Now $19.46 −14.20% ▲ +0.26% +0.35% vs SPY
  5. Sep 15, 20268w ago Insider Buy Bullish 5/10 Viewing Entry $21.18 to $21.93 Now $19.46 −8.12% ▲ +3.54% +2.41% vs SPY
  6. Aug 5, 202614w ago 8-K Bullish 7/10 Entry $27.42 to $27.67 Now $19.46 −29.03% ▲ +0.91% +1.07% vs SPY
  7. Jul 24, 202616w ago 8-K Bullish 7/10 Entry $29.64 to $30.22 Now $19.46 −34.35% ▲ +1.96% +1.94% vs SPY
  8. Apr 8, 202631w ago Press Release Neutral 5/10 Entry $34.01 to $35.07 Now $19.46 −42.78% ▲ +3.12% +2.54% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 6h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026